Cargando…
Current and Emerging Pharmacotherapy for Fibromyalgia
Introduction. Fibromyalgia syndrome (FMS) is a pain disorder with an estimated prevalence of 1–5%. It is associated with a variety of somatic and psychological disorders. Its exact pathogenesis is still unclear but is involved with neural oversensitization and decreased conditioned pain modulation (...
Autores principales: | Tzadok, Roie, Ablin, Jacob N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036118/ https://www.ncbi.nlm.nih.gov/pubmed/32104521 http://dx.doi.org/10.1155/2020/6541798 |
Ejemplares similares
-
Pharmacotherapy for Fibromyalgia
por: Smith, Howard S., et al.
Publicado: (2011) -
Spa Treatment (Balneotherapy) for Fibromyalgia—A Qualitative-Narrative Review and a Historical Perspective
por: Ablin, Jacob N., et al.
Publicado: (2013) -
Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies
por: Maffei, Massimo E.
Publicado: (2020) -
Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
por: Prodduturi, Prathima, et al.
Publicado: (2012) -
Pharmacotherapy for uveitis: current management and emerging therapy
por: Barry, Robert J, et al.
Publicado: (2014)